PM ETOCALA, Fla., Oct. 09, 2024 (GLOBE NEWSWIRE) -- (NYSE American: AIM) (“AIM” or the “Company”), announced today that Tom ...

Detailed price information for Aim Immunotech Inc (AIM-A) from The Globe and Mail including charting and trades.

Discover Alnylam Pharmaceuticals' groundbreaking patent for RNAi agents targeting the Serpina1 gene, offering innovative treatments for liver disorders and beyond.

The great thing about dsRNA and antisense oligonucleotides are that they are highly specific, meaning that they only affect the organism that it is intended to affect, since it is made to that ...

Non-exclusive license includes HiFi DNA Polymerase, HiTemp Reverse Transcriptase, HiRev Isothermal Polymerase and other enzymes for genomics and diagnostic applicationsREDWOOD CITY, Calif., Oct. 01, ...

ICAR-NBAIR discovered 63 new insect species in 2023-2024, obtained five patents for innovations in pest management, and ...

TriLink BioTechnologies and Alphazyme, both part of Maravai LifeSciences, have collaborated to launch CleanScribe™ RNA ...

OCALA, Fla., Sept. 30, 2024 (GLOBE NEWSWIRE) -- (NYSE American: AIM) (“AIM” or the “Company”) today announced that it has ...

The new product reduces dsRNA by up to 85%, helping to develop safer, more potent mRNA therapeutics. CleanScribe RNA Polymerase is a novel DNA-dependent RNA polymerase that catalyzes the in vitro ...

Study reveals widespread dysregulation of transposable elements (TEs) in aging human brains with Alzheimer's disease, using ...

USPTO grants patent to AIM ImmunoTech’s Ampligen for endometriosis treatment: Ocala, Florida Monday, October 7, 2024, 15:00 Hrs [IST] AIM ImmunoTech Inc. announced that the Unit ...